Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | 22,554 | reported | 04 Mar 2026 | tx 15+151,850−57,457 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Mar 2026 | SALE | Monte Rosa Therapeutics, Inc. | 139 | 17.96 USD | |
| 02 Mar 2026 | SALE | Monte Rosa Therapeutics, Inc. | 536 | 17.50 USD | |
| 02 Mar 2026 | EXERCISE | Monte Rosa Therapeutics, Inc. | 536 | 13.41 USD | |
| 27 Feb 2026 | EXERCISE | Monte Rosa Therapeutics, Inc. | 25,164 | 13.41 USD | |
| 27 Feb 2026 | SALE | Monte Rosa Therapeutics, Inc. | 25,164 | 18.10 USD | |
| 02 Mar 2026 | EXERCISE | Monte Rosa Therapeutics, Inc. | 536 | 0.00 USD | deriv |
| 27 Feb 2026 | EXERCISE | Monte Rosa Therapeutics, Inc. | 25,164 | 0.00 USD | deriv |
| 05 Jan 2026 | SALE | Monte Rosa Therapeutics, Inc. | 1,039 | 15.17 USD | |
| 03 Jun 2025 | SALE | Monte Rosa Therapeutics, Inc. | 2,062 | 4.45 USD | |
| 02 Jan 2025 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 11,850 | — | |
| 02 Jan 2025 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 53,400 | 0.00 USD | deriv |
| 05 Jul 2024 | SALE | Monte Rosa Therapeutics, Inc. | 1,610 | 3.83 USD | |
| 03 Jun 2024 | SALE | Monte Rosa Therapeutics, Inc. | 1,207 | 4.04 USD | |
| 02 Jan 2024 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 35,900 | 0.00 USD | deriv |